- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
Volume 42, Issue 1, Pages 7-16
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-12-06
DOI
10.1097/jcp.0000000000001513
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Post-diagnostic antipsychotic use and cancer mortality: a population based cohort study
- (2020) Blánaid M. Hicks et al. BMC CANCER
- Prolactin and Estrogen Levels in Postmenopausal Women Receiving Aripiprazole Augmentation Treatment for Depression
- (2020) Tahir Rahman et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Graphical Depiction of Longitudinal Study Designs in Health Care Databases
- (2019) Sebastian Schneeweiss et al. ANNALS OF INTERNAL MEDICINE
- Breast Cancer Screening in Women With Schizophrenia: A Systematic Review and Meta-Analysis
- (2019) Alison Hwong et al. PSYCHIATRIC SERVICES
- Use of antipsychotics and risk of breast cancer: a Danish nationwide case-control study
- (2018) Anton Pottegård et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Is parity status associated with bipolar disorder clinical features, severity or evolution?
- (2018) Sarah Tebeka et al. JOURNAL OF AFFECTIVE DISORDERS
- Female schizophrenia patients and risk of breast cancer: A population-based cohort study
- (2017) Ana Isabel Wu Chou et al. SCHIZOPHRENIA RESEARCH
- Risk of breast cancer in risperidone users: A nationwide cohort study
- (2017) Johan Reutfors et al. SCHIZOPHRENIA RESEARCH
- Modification of claims-based measures improves identification of comorbidities in non-elderly women undergoing mastectomy for breast cancer: a retrospective cohort study
- (2016) Katelin B. Nickel et al. BMC HEALTH SERVICES RESEARCH
- Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study
- (2016) Young-Min Park et al. PSYCHIATRY RESEARCH
- Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review
- (2015) M. De Hert et al. ACTA PSYCHIATRICA SCANDINAVICA
- Prolactin and breast cancer: The need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: A review
- (2015) Denise Froes Brandao et al. CANCER
- Antipsychotic Treatment in Breast Cancer Patients
- (2014) Tahir Rahman et al. AMERICAN JOURNAL OF PSYCHIATRY
- Increased Risk of Surgical Site Infection Among Breast-Conserving Surgery Re-excisions
- (2014) Margaret A. Olsen et al. ANNALS OF SURGICAL ONCOLOGY
- Validation of Rosner–Colditz breast cancer incidence model using an independent data set, the California Teachers Study
- (2013) B. A. Rosner et al. BREAST CANCER RESEARCH AND TREATMENT
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis
- (2012) John Cookson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The use of atypical antipsychotics and the risk of breast cancer
- (2011) Laurent Azoulay et al. BREAST CANCER RESEARCH AND TREATMENT
- Hyperprolactinemia associated with psychotropics-a review
- (2010) Subramoniam Madhusoodanan et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Antipsychotic-Induced Hyperprolactinemia
- (2008) Jolene R Bostwick et al. PHARMACOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started